Abstract
Objectives: The aim of this review was to examine the prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population. Methods: A systematic search of studies related to chronic heart failure (CHF) in the diabetic population was performed using medical databases. Results: 1) The prevalence of CHF in the diabetic population was approximately 10-23% in the large previously studied cohort. This was about three times higher than in nondiabetic control groups. 2) The incidence of CHF in diabetes varied greatly. It was influenced by the time of follow-up, the mean age of patients, the state of metabolic control and the complications of diabetes. The incidence of CHF in patients with diabetes was approximately two-fold greater than in the non-diabetic population. 3) The main risk factors of CHF in the type 2 diabetic population were age, hemoglobin A1c (HbA1c), coronary heart disease, hypertension, microalbuminuria and obesity. Conclusions: The prevalence and incidence of CHF were found to be high in the diabetic population, and the risk factors of CHF were somewhat different from those in the general population.
Keywords: Prevalence, Incidence, Risk factors, Chronic heart failure, Diabetes, Systematic review
Current Diabetes Reviews
Title: Prevalence, Incidence and Risk Factors of Chronic Heart Failure in the Type 2 Diabetic Population: Systematic Review
Volume: 5 Issue: 3
Author(s): Linuo Zhou, Wei Deng, Lixue Zhou, Ping Fang, Daikun He, Weiwei Zhang, Kui Liu and Renming Hu
Affiliation:
Keywords: Prevalence, Incidence, Risk factors, Chronic heart failure, Diabetes, Systematic review
Abstract: Objectives: The aim of this review was to examine the prevalence, incidence and risk factors of chronic heart failure in the type 2 diabetic population. Methods: A systematic search of studies related to chronic heart failure (CHF) in the diabetic population was performed using medical databases. Results: 1) The prevalence of CHF in the diabetic population was approximately 10-23% in the large previously studied cohort. This was about three times higher than in nondiabetic control groups. 2) The incidence of CHF in diabetes varied greatly. It was influenced by the time of follow-up, the mean age of patients, the state of metabolic control and the complications of diabetes. The incidence of CHF in patients with diabetes was approximately two-fold greater than in the non-diabetic population. 3) The main risk factors of CHF in the type 2 diabetic population were age, hemoglobin A1c (HbA1c), coronary heart disease, hypertension, microalbuminuria and obesity. Conclusions: The prevalence and incidence of CHF were found to be high in the diabetic population, and the risk factors of CHF were somewhat different from those in the general population.
Export Options
About this article
Cite this article as:
Zhou Linuo, Deng Wei, Zhou Lixue, Fang Ping, He Daikun, Zhang Weiwei, Liu Kui and Hu Renming, Prevalence, Incidence and Risk Factors of Chronic Heart Failure in the Type 2 Diabetic Population: Systematic Review, Current Diabetes Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157339909788920938
DOI https://dx.doi.org/10.2174/157339909788920938 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effectiveness of Psychoeducational Interventions for Improving Symptoms, Health-Related Quality of Life, and Psychological well Being in Patients with Stable Angina
Current Cardiology Reviews Improving Red Blood Cell K-Uptake and its Impact on O2/CO2 Exchange, and NO-Generation in Microvascular CHD: A Novel Therapeutic Approach
Recent Patents on Cardiovascular Drug Discovery Light Directed Gene Transfer by Photochemical Internalisation
Current Gene Therapy Crocetin Attenuates Spatial Learning Dysfunction and Hippocampal Injury in a Model of Vascular Dementia
Current Neurovascular Research T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Clinical Observation of Liver Chemistry Abnormalities in Asthmatics
Current Drug Safety Chemotherapeutic Options for Colorectal Cancer Patients with Cardiovascular Diseases.
Reviews on Recent Clinical Trials Efficacy of Adjunctive Brexpiprazole in Patients with Major Depressive Disorder: A Clinical Overview
Current Psychiatry Reviews The Role of Neuropeptides and Neurohormones in Neurogenic Cardiac Arrhythmias
Current Drug Targets - Cardiovascular & Hematological Disorders Congenital Duodenal Obstruction: The Impact of Downs Syndrome in Neonatal Morbidity. A Two-Center Survey
Current Pediatric Reviews Prostaglandin J2 Family and the Cardiovascular System
Current Vascular Pharmacology Inflammatory Biomarkers in Peripheral Artery Disease: Diagnosis, Prognosis, and Therapeutic Challenges
Current Medicinal Chemistry Concerning Arterial Hypertension, Homocysteine and Paraoxonase-1
Current Hypertension Reviews The Fallacy of the Longevity Elixir: Negligible Senescence May be Achieved, but Not by Using Something Physical
Current Aging Science Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner?
Current Cardiology Reviews Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario
Current Topics in Medicinal Chemistry PCSK9 and LDLR The Yin-Yang in the Cellular Uptake of Cholesterol
Current Hypertension Reviews Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema
Current Drug Safety Significant Overlapping Modules and Biological Processes Between Stroke and Coronary Heart Disease
CNS & Neurological Disorders - Drug Targets Editorial
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents